{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:57:23Z","timestamp":1792803443556,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Synoptik Foundation"},{"name":"Fight for Sight"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jtos.2020.11.013","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T20:52:37Z","timestamp":1606510357000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8537-7816","authenticated-orcid":false,"given":"Michael","family":"M\u00f8ller-Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrine","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Bjerre","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Duch","family":"Lynggaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Bruunsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-8012","authenticated-orcid":false,"given":"Mandana","family":"Haack-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Ekblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2020.11.013_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0420.1997.tb00774.x","article-title":"Keratoconjunctivitis sicca and primary Sj\u00f6gren\u2019s syndrome in a Danish population aged 30-60 years","volume":"75","author":"Bjerrum","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jtos.2020.11.013_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtos.2020.11.013_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jtos.2020.11.013_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcyt.2018.01.009","article-title":"MSCs\u2014cells with many sides","volume":"20","author":"Le Blanc","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtos.2020.11.013_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.jtos.2020.11.013_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jtos.2020.11.013_bib11","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/sctm.17-0040","article-title":"Cryopreserved off-the-shelf allogeneic adipose-derived stromal cells for therapy in patients with ischemic heart disease and heart failure-A safety study","volume":"6","author":"Kastrup","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jtos.2020.11.013_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biochi.2004.11.007","article-title":"The human adipose tissue is a source of multipotent stem cells","volume":"87","author":"Rodriguez","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.jtos.2020.11.013_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jtos.2019.01.006","article-title":"The therapeutic application of mesenchymal stem cells at the ocular surface","volume":"17","author":"Sahu","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/mt.2014.159","article-title":"Mesenchymal stem\/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye","volume":"23","author":"Lee","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtos.2020.11.013_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3134543","article-title":"Delivery of bone marrow-derived mesenchymal stem cells improves tear production in a mouse model of Sj\u00f6gren\u2019s syndrome","volume":"2017","author":"Aluri","year":"2017","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.jtos.2020.11.013_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0090-1229(79)90052-7","article-title":"A disorder of dogs resembling Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Quimby","year":"1979","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jtos.2020.11.013_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/527926","article-title":"Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model","volume":"2015","author":"Villatoro","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtos.2020.11.013_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/215517916X693366","article-title":"Allogeneic mesenchymal stem cell transplantation in dogs with keratoconjunctivitis sicca","volume":"8","author":"Bittencourt","year":"2016","journal-title":"Cell Med"},{"key":"10.1016\/j.jtos.2020.11.013_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2020.11.013_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365513.2018.1462082","article-title":"Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysate","volume":"78","author":"Haack-S\u00f8rensen","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jtos.2020.11.013_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ejhf.1412","article-title":"Rationale and design of the European multicentre study on stem cell therapy in IschEmic non-treatable cardiac diseasE (SCIENCE)","volume":"21","author":"Paitazoglou","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtos.2020.11.013_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8506370","article-title":"Rationale and design of the first double-blind, placebo-controlled trial with allogeneic adipose tissue-derived stromal cell therapy in patients with ischemic heart failure: a phase II Danish multicentre study","volume":"2017","author":"Kastrup","year":"2017","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.jtos.2020.11.013_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.eye.6700230","article-title":"Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland","volume":"16","author":"Montoya","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2020.11.013_bib25","series-title":"Common Terminology criteria for adverse events (CTCAE) v5.0","author":"Cancer Institute","year":"2017"},{"key":"10.1016\/j.jtos.2020.11.013_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2020.11.013_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225680","article-title":"The importance of HLA assessment in \u201coff-the-shelf\u201d allogeneic mesenchymal stem cells based-therapies","author":"Kot","year":"2019","journal-title":"Mol Sci"},{"key":"10.1016\/j.jtos.2020.11.013_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038615","article-title":"Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sj\u00f6gren\u2019s-like disease","volume":"7","author":"Khalili","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2020.11.013_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jtos.2020.11.013_bib30","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.5.6.16","article-title":"Lower vitamin D level and distinct tear cytokine profile were observed in patients with mild dry eye signs but exaggerated symptoms","volume":"5","author":"Shetty","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2020.11.013_bib31","article-title":"Palpebral lobe of the human lacrimal gland: morphometric analysis in normal versus dry eyes","author":"Singh","year":"2020","journal-title":"Br J Ophthalmol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012420301828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012420301828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:41:20Z","timestamp":1761540080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012420301828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"alternative-id":["S1542012420301828"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2020.11.013","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2020.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}